CSF3 and pelvic inflammatory disease: Although the PID cohort is diagnostically diverse, including FA, SCN, AN, PLS and PN, the clinical data indicate that, despite differences in aetiology and additional treatments (e.g., G‐CSF, azithromycin and prior dental interventions), the microbiomes at baseline were broadly similar based on alpha/beta diversity metrics and the rarefied species abundances (Figures 1, 2 and S2).